Auto Cpap

Jiangsu Pharmaceutical Co., Ltd. is a wholly-owned holding company of Jiangsu Guoxin Asset Management Group Co., Ltd., a leading state-owned enterprise in Jiangsu Province, with a registered capital of 266.13 million yuan.By the end of 2019, the net assets of the company were 530 million yuan, with total assets of 3.744 billion yuan.

Established in 1953, Jiangsu Pharmaceutical Co., Ltd. is engaged in the wholesale and retail business of pharmaceuticals, medical devices and medicinal materials, etc. Currently, it has 290 regular employees, 20 departments and 3 branches.Jiangsu Pharmaceutical was transformed from an administrative company to an operating company in 1988, and became a wholly-owned subsidiary of Jiangsu Guoxin Group Co., Ltd in 2006. In 2009, Jiangsu Pharmaceutical merged with Provincial Pharmaceutical Materials Company and Provincial Medical Device Industry Company to form a new Jiangsu Pharmaceutical. In 2016, the company system was restructured, and in 2019, the mixed ownership reform was completed.

At present, the company with more than 3000 international and domestic customers keep close business contacts, business scope covers chemical drugs, biological products, narcotic drugs, psychotropic drugs, toxic drugs for medical use, proprietary Chinese medicine, Chinese herbal medicine, Chinese medicine yinpian, and medical devices, glass apparatus, chemical reagents, vaccine wholesale, retail, traditional Chinese medicinal materials acquisition, consulting service, medical information consulting services, exhibition services, sales of cosmetics and so on.

Jiangsu Pharmaceutical Co., Ltd., as a state-owned pharmaceutical commercial enterprise wholly owned by the province, has become the pharmaceutical commercial company with the most comprehensive market coverage in Nanjing region by accelerating the pace of transformation and upgrading, improving the management level and service ability, optimizing customer base and regional market segmentation.As a provincial drug shortage storage unit, it has actively undertaken the drug shortage storage tasks in five cities including Ning, Su, Xi, Chang and Zhen. Its business covers the whole province of Jiangsu and radiates to surrounding provinces and cities.It is a state-designated regional wholesale enterprise of anesthetic and essence drugs, a national herbal medicine reserve enterprise, a provincial pharmaceutical and medical device reserve enterprise in Jiangsu Province, and one of the only four drug shortage storage enterprises in Jiangsu Province.

Company Profile

BMC Medical Co., Ltd. is the leading developer, manufacturer and supplier of products and service for the diagnosis and therapy of sleep-disordered breathing in China.

Professional R&D

Since 1996, launched the first polysomnograph (PSG) in China, BMC has continuously introduced innovative sleep diagnostic systems, covering the various requirements of sleep holter, polysomnograph, CPAP titration and sleep research. Up till now, BMC's sleep diagnostic system has been in the fourth generation of all digital technology. Its outstanding features and quality make BMC the leader of sleep diagnosis in China.

After years of research and development, BMC now owns the innovative technology of nPAP and releases RESmart series, the intelligent CPAP and AutoCPAP in Q4 2007. RESmart adopts the most advanced sensor and control technology. It must be the milestone of becoming specialist of sleep diagnosis and therapy.

Proven Product Quality

BMC always cultivates international quality concept and improves manufacturing procedure. We have obtained ISO-9000/13485 and CE certificates.

Advanced Service Concept

BMC has established a well-built sales and service system. We always strive for continuous quality improving and maximum customer satisfaction.

Company Value

Specialist of Sleep Diagnosis and Therapy

Hunan Ventmed Medical Technology Co., Ltd.(trademark:VENTMED)is a National High-tech enterprise based in China and engaged in the research, development, production and sales of non-invasive ventilators, medical sleep diagnostic monitors and other medical devices around the world.The company was founded in 2013 and R&D began in 2003,It is one of the earliest enterprises to develop non-invasive ventilator(CPAP/BIPAP) in China.At present, the two main series products are "CPAP /BIPAP" and "Sleep monitor" ,Our technology is in the leading position in China, and we have obtained more than 60 patents, intellectual property rights and scientific and technological achievements.After years of continuous development, there are more than 2,000 square meters of modern production plant, monthly production can reach more than 6000sets CPAP or BIPAP.By 2020,we have obtained 8 international certifications, participated in more than 30 exhibitions, and our products are exported to more than 50 countries.

Two main series products:

Series 1: DS series non-invasive ventilator, Auto CPAP machine DS-6,BIPAP machine DS-7 and DS-8;

VM series non-invasive ventilator was launched in the first half of 2020;

RX series High Performance non-invasive ventilator will be launched in the second half of 2020.

Series 2: Sleep monitor: A9, Polysomnography (PSG): A18,A22 and A30.

In 2016, it was obtained ISO 13485 certification.

In 2017, it was awarded "National High-tech Enterprise" and "Top ten Innovative Figures" in Hunan Medical Industry.

In 2018, CE certification was obtained.

In 2019, it was selected as "National Superior Intellectual Property Enterprise";

In 2020,After the COVID-19 outbreak , we donated and sold more than 3,000 non-invasive BIPAP ventilators to the fight against COVID-19 Virus at home and abroad.

Adhering to the business philosophy of "focus on professionalism, focus on goals, quality first, continuous innovation", the company has been committed to improving product performance, investing in new product research and development, and persisting in stable quality , and striving to build VENTMED into a well-known brand in the global sleep-breathing industry.